Metastatic Colorectal Carcinoma

Oncology·MeSH: Colorectal Neoplasms

6 drugs in development·3 companies·6 clinical trials

Drug Pipeline by Phase

Phase 3(4)

Drug	Company
BET Bromodomain Inhibitor ZEN-3694	Merus N.V. (MRUS)
cetuximab	GH Research PLC (GHRS)
Fruquintinib	IGM Biosciences, Inc. (IGMS)
panitumumab	GH Research PLC (GHRS)

Phase 2(2)

Drug	Company
5 FU bolus	IGM Biosciences, Inc. (IGMS)
5 FU continuous	IGM Biosciences, Inc. (IGMS)

BioSniper tracks 6 drugs in development for Metastatic Colorectal Carcinoma across 3 companies.

There are 6 clinical trials targeting Metastatic Colorectal Carcinoma tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.